Skip to content

Simplera Sync Sensor, Guardian 4 Sensor

by Medtronic Minimed, Inc.

PMA P250012

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P250012↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP250012 Date6 Aug 2025ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic name
Sensor, Glucose, Invasive, Component of automated insulin delivery system
PMA number
FDA product code
SFI
Device class
Class III
Advisory committee
Clinical Chemistry
FDA decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Simplera Sync Sensor and Guardian 4 Sensor are invasive glucose sensors intended to function as components of a Medtronic automated insulin dosing system. They are designed to continuously monitor glucose levels in interstitial fluid to support automated insulin delivery.

These sensors are supplied as sterile, single-use components for use in clinical and home settings under the direction of a healthcare provider. They are not MRI safe unless explicitly stated in labeling, and storage conditions must follow manufacturer specifications. Authorization is based on FDA PMA P250012, with no additional claims made beyond the approved indications.

Other devices from Medtronic Minimed, Inc.

See all devices from Medtronic Minimed, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary function of the Simplera Sync Sensor and Guardian 4 Sensor?

    The Simplera Sync Sensor and Guardian 4 Sensor are invasive glucose sensors designed to continuously monitor glucose levels in interstitial fluid. They function as components of Medtronic's automated insulin dosing system, providing real-time data to support insulin delivery decisions.

  • Are the Simplera Sync Sensor and Guardian 4 Sensor reusable or single-use?

    The Simplera Sync Sensor and Guardian 4 Sensor are supplied as sterile, single-use components. They are intended for one-time use only and must be discarded after each application according to the manufacturer's instructions for use.

  • What regulatory authorization covers the Simplera Sync Sensor and Guardian 4 Sensor?

    The Simplera Sync Sensor and Guardian 4 Sensor are authorized under FDA Premarket Approval (PMA) P250012. This approval was granted on August 6, 2025, for their use as components of a Medtronic automated insulin delivery system.